Lactobacillus acidophilus

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Lactobacillus acidophilus
DrugBank Accession Number
DB15823
Background

Not Available

Type
Biotech
Groups
Approved, Experimental
Synonyms
  • Acidophilus
  • Bacillus acidophilus whole
  • Bacterium acidophilum whole
  • Lacteol
  • Lactobacillus acidophilus
  • Lactobacillus acidophilus whole
  • Lactobacterium acidophilum whole
  • Thermobacterium intestinale whole

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Treatment ofDiarrhea•••••••••••••••••••• ••• ••••••••
Maintenance ofIntestinal bacteria flora••• •••••••••••••••
Used in combination to treatVaginal dischargeCombination Product in combination with: Estriol (DB04573)••••••••••••••••••••••••••••• ••••••
Used in combination to treatVaginal flora imbalanceCombination Product in combination with: Estriol (DB04573)•••••••••••••••••••••••••••••• ••••••••••••••••••• ••••••
Used as adjunct in combination for symptomatic treatment ofVaginal symptomsCombination Product in combination with: Estriol (DB04573)••••••••••••••••••••••••••••• ••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Probiata TabletsTablet1 bOralPurity Life Health Products A Division Of Sunopta Inc.2001-09-012007-07-26Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Acidophilus Bifidum BulgaricusLactobacillus acidophilus (120 mg) + Bifidobacterium bifidum (120 mg) + Lactobacillus delbrueckii bulgaricus (120 mg)CapsuleOralNutraceutical Corporation2003-09-022006-08-02Canada flag
Gynoflor - VaginaltablettenLactobacillus acidophilus (50 mg) + Estriol (0.03 mg)TabletVaginalGedeon Richter Plc1990-02-09Not applicableAustria flag
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 12 ADETLactobacillus acidophilus (50 mg) + Estriol (0.03 mg)SuppositoryVaginalABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.1996-12-11Not applicableTurkey flag
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 6 ADETLactobacillus acidophilus (50 mg) + Estriol (0.03 mg)SuppositoryVaginalABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.1996-12-11Not applicableTurkey flag
MORELACLactobacillus acidophilus (10000000 CFU) + Lactobacillus delbrueckii bulgaricus (5000000 CFU) + Streptococcus thermophilus (4000000000 CFU)Powder, for suspensionOralProge Farm S.R.L.2014-07-08Not applicableItaly flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1PRR1V42V5
CAS number
68333-16-4

References

General References
Not Available
RxNav
6205
Wikipedia
Lactobacillus_acidophilus

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
4CompletedOtherAllergic Rhinitis (AR)1somestatusstop reasonjust information to hide
4CompletedTreatmentBacterial Vaginosis (BV) / Recurrences1somestatusstop reasonjust information to hide
4CompletedTreatmentDiarrhoea Predominant Irritable Bowel Syndrome1somestatusstop reasonjust information to hide
4CompletedTreatmentProbiotics / Type 1 Diabetes Mellitus1somestatusstop reasonjust information to hide
4Not Yet RecruitingTreatmentType 2 Diabetes Mellitus With Complication1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
TabletVaginal
Powder, for suspensionOral
CapsuleOral8000000000 [CFU]/1
CapsuleOral16000000000 [CFU]/1
TabletVaginal66.667 mg
SuppositoryVaginal
TabletOral
CapsuleOral20000000000 [CFU]/1
TabletVaginal
TabletOral1 b
CapsuleOral
CapsuleOral2 b / cap
CapsuleOral10000000000 [CFU]/1
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at September 10, 2020 16:02 / Updated at September 13, 2020 19:13